Evidence map›Paper›PMID 33805695›Full record

ArticleMicroorganisms2021

Effective Small Molecule Antibacterials from a Novel Anti-Protein Secretion Screen.

Mohamed Belal Hamed, Ewa Burchacka, Liselotte Angus, Arnaud Marchand, Jozefien De Geyter, Maria S Loos, Jozef Anné, Hugo Klaassen, Patrick Chaltin, Spyridoula Karamanou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Mohamed Belal HamedLaboratory of Molecular Bacteriology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-6383-4147
Ewa BurchackaLaboratory of Molecular Bacteriology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-2177-1800
Liselotte AngusCistim Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, 3001 Leuven, Belgium.
Arnaud MarchandCistim Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, 3001 Leuven, Belgium.
Jozefien De GeyterLaboratory of Molecular Bacteriology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.
Maria S LoosLaboratory of Molecular Bacteriology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.
Jozef AnnéLaboratory of Molecular Bacteriology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-0493-2644
Hugo KlaassenCistim Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, 3001 Leuven, Belgium.
Patrick ChaltinCistim Leuven vzw, Bioincubator 2, Gaston Geenslaan 2, 3001 Leuven, Belgium.
Spyridoula KaramanouLaboratory of Molecular Bacteriology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.
Anastassios EconomouLaboratory of Molecular Bacteriology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-1770-507X
Rega Institute for Medical Research · BEKU Leuven · BEWrocław University of Science and Technology · PL

Funding

Fonds Wetenschappelijk Onderzoek G0C6814N
6 · The paper itself

Abstract

The increasing problem of bacterial resistance to antibiotics underscores the urgent need for new antibacterials. Protein export pathways are attractive potential targets. The Sec pathway is essential for bacterial viability and includes components that are absent from eukaryotes. Here, we used a new high-throughput in vivo screen based on the secretion and activity of alkaline phosphatase (PhoA), a Sec-dependent secreted enzyme that becomes active in the periplasm. The assay was optimized for a luminescence-based substrate and was used to screen a ~240K small molecule compound library. After hit confirmation and analoging, 14 HTS secretion inhibitors (HSI), belonging to eight structural classes, were identified with IC

Indexed as

alkaline phosphataseantibacterialsE. coliprotein secretionsmall molecule inhibitors

Identifiers

PMID33805695
PMCPMC8000395
OpenAlexW3136825209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.